Overview

Evidence and Insights: Making the Case for Greater CVD Risk Reduction was a satellite symposium at the AHA annual meeting in November 2006. The program brought together expert faculty in the area of cardiovascular disease (CVD) risk assessment, screening, and treatment to examine CVD risk factors and risk reduction.

The format included short presentations by faculty members followed by periods of discussion in an attempt to draw out key issues and controversies in the area of CVD risk reduction. A lively conversation between the faculty brought to light some interesting challenges in the context of primary and secondary CVD prevention: How useful is the Framingham Risk Assessment Tool, and what are the limitations that need to be considered? Is LDL-C the best marker for risk assessment and response to therapy in primary prevention? What other potential biomarkers may offer additional prognostic impact to the arena of primary and secondary CVD risk prevention?

This newsletter highlights some of the main points from each presentation and provides insights based on discussions throughout the program.

	moderator
	Daniel J. Rader, MD Cooper-McClure Professor of Medicine Pathology, and Pharmacology Director, Preventive Cardiovascular Medicine and Lipid Clinic Director, General Clinical Research Center Associate Director Institute for Translational Medicine and Therapeutics University of Pennsylvania School of Medicine Philadelphia, PA
	speakers
	Roger S. Blumenthal, MD, FACC, FCCP, FAHA Associate Professor of Medicine Division of Cardiology Director, Preventive Cardiology Johns Hopkins Hospital Baltimore, MD		Lori J. Mosca, MD, MPh, PhD Associate Professor of Medicine Columbia University College of Physicians and Surgeons Director, Preventive Cardiology New York-Presbyterian Hospital Director, Columbia Center for Heart Disease Prevention New York, NY
	Allan D. Sniderman, MD Edwards Professor of Cardiology Professor of Medicine McGill University Director, Mike Rosenbloom Laboratory for Cardiovascular Research Royal Victoria Hospital Montreal, Quebec		Christopher P. Cannon, MD Associate Professor of Medicine Harvard Medical School Associate Physician, Cardiovascular Division Brigham and Women's Hospital Boston, MA